Biopharma/Biotech Analyst Chen & Biotech Analyst Agrawal, along with Drs. Pajvani & Acholonu discuss obesity and related metabolic diseases post American Diabetes Association’s sessions (relevant companies NVO, LLY, PFE, AMGN, VKTX, RYTM) on an Analyst/Industry conference call to be held on June 28 at 1 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NVO:
- REGN, CTLT Continue Sliding Following FDA Rejection of Eylea Drug
- Pharmaceutical companies are developing drugs to surpass Ozempic, WSJ reports
- Eli Lilly (NYSE:LLY) Touts Superior Results of Weight Loss Shot
- Pfizer’s (NYSE:PFE) Oral Obesity Drug Plans Get Leaner
- Cantor biotech/biopharma analysts hold analyst/industry conference call